Prosecution Insights
Last updated: October 04, 2026

Wood, Phillips, Katz, Clark & Mortimer

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

69 pending office actions • 55 clients • 65 examiners • 37 art units • 0 of 69 (0%) have an AI response strategy ready • 101 patents granted in the last 365 days

Analysis

WOOD, PHILLIPS, KATZ, CLARK & MORTIMER specializes in Biotechnology & Pharmaceuticals, with 5371 career applications. The firm currently manages 56 pending office actions. It has a resolved allowance rate of 78.81 percent, which serves as a baseline for its success in the life sciences sector. The firm averages 3.06 office actions per allowance, indicating a standard prosecution timeline for biotechnology patents.

This average of 3.06 suggests that the firm typically requires three rounds of interaction with examiners to secure an allowance. With 5371 career applications, the 78.81 percent allowance rate shows a consistent ability to navigate the complex regulatory and technical requirements of the USPTO. For practitioners, the 56 pending office actions indicate an active practice in a highly specialized field. The firm's ability to maintain a 78.81 percent allowance rate while averaging 3.06 office actions per allowance across 5371 career applications demonstrates its established presence and reliability in the Biotechnology & Pharmaceuticals sector, providing a clear track record for its clients.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=5371 apps, methodology: how we score firms)

78.8%
Allowance Rate
n=5371
+0.55σ
Allowance Rate (norm)
n=5371
3.1
OAs to Allowance
n=3084
-0.22σ
OAs to Allow (norm)
n=3084
1095 days
Time to Allowance
n=3084
+11.6pp
Interview Lift
n=5371
21.4%
RCE Rate
n=5371
2.9%
Appeal Rate
n=5371

Rejection Performance (% of received rejections ultimately overcome)

71.6%
§101 Overcome
n=190
75.9%
§102 Overcome
n=1128
76.3%
§103 Overcome
n=1815
77.2%
§112 Overcome
n=1302

Specialization & Scale

A61K, A01N, B65D
Top CPC Subclasses
15%
Top-3 CPC Share
n=5371
2
Practitioners
n=5371
2685.5
Apps / Practitioner
n=5371

Portfolio Summary

69
Total Pending OAs
46
Non-Final OAs
21
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
0
Due this week
3
Due this month
2
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 30 days (3)Due ≤ 60 days (2)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

34
Hard (49%)
29
Medium (42%)
5
Easy (7%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other5 (7%)
§103 only22 (32%)
§102 only2 (3%)
§112 only3 (4%)
Double-patenting only2 (3%)
Double-patenting + other5 (7%)
Multi-statute (no §101)28 (41%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

32
Life Sciences
46% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
1% of docket
15
Mechanical / Eng
22% of docket
21
Business / Other
30% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

690 h
Manual time on pending OAs
138 h
Time saved (low, 20%)
241 h
Time saved (mid, 35%)
6.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUTCHLER, CHRISTOPHER JOHN 2 55.9% +20.4%
HAGOPIAN, CASEY SHEA 2 54.4% +33.3%
BREEN, KIMBERLY CATHERINE 2 23.8% +56.9%
HAGHIGHATIAN, MINA 2 46.1% +39.3%
HWU, JUNE 1 91.3% -2.0%
ATKINSON, JOSHUA ALEXANDER 1 52.4% +26.7%
CHEN, JOSE V 1 78.0% +15.1%
COOLEY, CHARLES E 1 79.0% +15.2%
AURORA, REENA 1 87.1% -13.4%
MCDUFFIE, MICHAEL D 1 67.6% -10.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18290141 A Probe Card Stroke Compensation System and Method AURORA, REENA —

Hard Cases (35)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18565915 VISUAL PROTECTION DEVICE FOR TASK FORCES FISSEL, TRAVIS S 59d overdue
18204867 METHOD OF ASSEMBLING CONDUIT SECTIONS LEGASPI, EUGENE REY DEVERA 22d
18289530 COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE LARA, CAROLINE MONSERRAT 33d
17389556 ANTI-VIRAL COMPOSITIONS AND METHODS OF USE THEREOF MERCIER, MELISSA S 56d
18700205 MEDICAL WATCH FOR MEASURING PHYSIOLOGICAL PARAMETERS PAHAKIS, MANOLIS Y 82d
19293288 METHODS OF IMPROVING STRESS TOLERANCE, GROWTH AND YIELD IN PLANTS HWU, JUNE —
19172028 METHOD FOR THE TREATMENT OF MALARIA MUTCHLER, CHRISTOPHER JOHN —
19080145 AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF ATKINSON, JOSHUA ALEXANDER —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17699405 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF HAGHIGHATIAN, MINA 267d overdue
17405773 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF HAGHIGHATIAN, MINA 267d overdue
16852870 MIXTURES OF SABADILLA ALKALOIDS AND PYRETHROIDS AND USES THEREOF HAGOPIAN, CASEY SHEA 70d
19172028 METHOD FOR THE TREATMENT OF MALARIA MUTCHLER, CHRISTOPHER JOHN —
19080145 AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF ATKINSON, JOSHUA ALEXANDER —
19075507 MULTI-POSITIONAL ARTICULATING ERGONOMIC DEVICE WITH MODULAR FEATURES CHEN, JOSE V —
19047191 MIXING AND KNEADING MACHINE COOLEY, CHARLES E —
19045529 ENDOSCOPE VISUAL FIELD-SECURING VISCOELASTIC COMPOSITION HAGOPIAN, CASEY SHEA —

Client Portfolio (55 clients)

Top Art Units

Art UnitApps
16574
37963
16173
16612
37262
17642
16332
16162
41001
36431

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19293288 METHODS OF IMPROVING STRESS TOLERANCE, GROWTH AND YIELD IN PLANTS Valent Biosciences LLC HWU, JUNE 1661 §103§112 Non-Final OA — Pending Aug 07, 2025
19172028 METHOD FOR THE TREATMENT OF MALARIA Instituto De Investigaciones Cientificas Y Servicios De Alta Technologia MUTCHLER, CHRISTOPHER JOHN §102§103 Non-Final OA — Pending Apr 07, 2025
19080145 AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF Valent Biosciences LLC ATKINSON, JOSHUA ALEXANDER §103§112 Non-Final OA — Pending Mar 14, 2025
19075507 MULTI-POSITIONAL ARTICULATING ERGONOMIC DEVICE WITH MODULAR FEATURES Fellowes Inc. CHEN, JOSE V DP Non-Final OA — Pending Mar 10, 2025
19047191 MIXING AND KNEADING MACHINE Buss AG COOLEY, CHARLES E §103 Final Rejection — Pending Feb 06, 2025
18290141 A Probe Card Stroke Compensation System and Method Shanghai Zenfocus Semi-Tech Co., Ltd. AURORA, REENA §112 Non-Final OA — Pending Feb 06, 2025
19045529 ENDOSCOPE VISUAL FIELD-SECURING VISCOELASTIC COMPOSITION Otsuka Pharmaceutical Factory, Inc. HAGOPIAN, CASEY SHEA §102§103§112 Non-Final OA — Pending Feb 04, 2025
19044281 METHOD AND ASSEMBLY FOR DISPLAYING AND SECURING A WEARABLE DEVICE AGAINST THEFT Se-Kure Controls, Inc. MCDUFFIE, MICHAEL D 4100 §102§103 Non-Final OA — Pending Feb 03, 2025
19099977 PAIR OF GOGGLES FOR ANIMALS OF THE EQUINE SPECIES Equidiva ALMATRAHI, SAHAR FARIS 3643 §102§103§112 Final Rejection — Pending Jan 30, 2025
18997448 DISPENSING CLOSURE FOR A CONTAINER AND CONTAINER WITH SUCH A DISPENSING CLOSURE Aptar Freyung GmbH LONG, DONNELL ALAN §102§103 Non-Final OA — Pending Jan 21, 2025
18877811 CHAIR Keter Home And Garden Products Ltd. ALEKSIC, NEVENA 3647 §102§103 Non-Final OA — Pending Dec 20, 2024
18968452 RESEALABLE, REUSABLE, RECYCLABLE SECONDARY PACKAGING TRANSPORT BAG Petoskey Plastics HELVEY, PETER N. §103 Non-Final OA — Pending Dec 04, 2024
18962574 MOUNTING BRACKET FOR ELECTRICAL BOX S-P Products, Inc. HOLLY, LEE A 3726 §102 Non-Final OA — Pending Nov 27, 2024
18944146 (S)-ABSCISIC ACID FOR REDUCING FRUIT DROP Valent Biosciences LLC CONIGLIO, AUDREA JUNE BUCKLEY §103§112 Non-Final OA — Pending Nov 12, 2024
18860530 A GARMENT ASSEMBLY FOR TRIGGERING, FACILITATING OR RESISTING MOVEMENT Dennisson Technologies Limited HURLEY, SHAUN R §103 Non-Final OA — Pending Oct 25, 2024
18898156 TRANSITION COUPLING AND CONDUIT ASSEMBLY S-P Products, Inc. LINFORD, JAMES ALBERT 3679 §103 Non-Final OA — Pending Sep 26, 2024
18849303 HOLDING PLATE FOR MULTIPLE SCREW DIAMETERS Ejot SE & Co. Kg MCCALISTER, WILLIAM M §103§112 Non-Final OA — Pending Sep 20, 2024
18888671 METHOD FOR TRAINING AUTONOMOUS DRIVING MODEL, METHOD FOR PREDICTING AUTONOMOUS DRIVING VIDEO, ELECTRONIC DEVICE, AND STORAGE MEDIUM Shanghai Artificial Intelligence Innovation Center TSAI, TSUNG YIN §102§103 Non-Final OA — Pending Sep 18, 2024
18776542 THERMAL CLEANING AND DISINFECTING DEVICE W & H Sterilization S.r.l. PILSBURY, BRADY CHARLES §102§103§112 Non-Final OA — Pending Jul 18, 2024
18729261 DOMESTIC APPLIANCE FOR DISPENSING DRINKING WATER Buse Ksw GmbH & Co. Kg PATEL, PRANAV N §103§112 Non-Final OA — Pending Jul 16, 2024
18723782 EDGE FUNCTIONALISED GRAPHENE THERMAL NANOFLUIDS Sicona Battery Technologies Pty Ltd., NGUYEN, TRI V 1764 §103 Non-Final OA 9d overdue Pending Jun 24, 2024
18720436 NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF Ildong Pharmaceutical Co., Ltd. NOTTINGHAM, KYLE GREGORY §103DP Non-Final OA — Pending Jun 14, 2024
18714529 A DEVICE FOR AFFECTING VASCULAR BLOOD FLOW AND METHODS THEREOF Novapulse Ltd. GROSS, JASON PATRICK 3797 §103 Non-Final OA 30d overdue Pending May 29, 2024
18713073 Surgical Apparatus Nallakrishnan Family Trust RITCHIE, HADEN MATTHEW §103 Non-Final OA — Pending May 23, 2024
18669120 DISTRIBUTED MODEL TRAINING METHOD, DEVICE, AND MEDIUM Shanghai Artificial Intelligence Innovation Center ALI, NAYMUR RAHMAN §101§103§112 Non-Final OA — Pending May 20, 2024
18663567 STONE FRUIT QUALITY Valent Biosciences LLC DIOU BERDECIA, LUIS EUGENIO 1792 §103§112 Final Rejection — Pending May 14, 2024
18705431 TISSUE-SPECIFIC PROMOTER AND USE THEREOF BEIJING MEIKANG GENO-IMMUNE BIOTECHNOLOGY CO., LTD. ROGERS, ERIC JASON §103§112 Non-Final OA — Pending Apr 26, 2024
18700205 MEDICAL WATCH FOR MEASURING PHYSIOLOGICAL PARAMETERS Cardiacsense Ltd. PAHAKIS, MANOLIS Y 3796 §103§112 Non-Final OA 82d Pending Apr 10, 2024
18293154 PHACOEMULSIFICATION NEEDLE Raico International, LLC DIOP, FATIMATA SAHRA 3783 §103 Non-Final OA — Pending Jan 29, 2024
18420254 DISPLAY WITH REFLECTIVE SURFACE Se-Kure Controls, Inc. LEWIS, JUSTIN V 3637 §103 Final Rejection — Pending Jan 23, 2024
18571648 LEPTIN RECEPTOR AFFINITY PEPTIDE AND USE THEREOF Dubu Biosciences BORGEEST, CHRISTINA M §101§103§112 Non-Final OA — Pending Dec 18, 2023
18565915 VISUAL PROTECTION DEVICE FOR TASK FORCES Rubi Glas GmbH FISSEL, TRAVIS S 2872 §102§112 Final Rejection 59d overdue Pending Nov 30, 2023
18560042 FIRING FURNACE Denken-Highdental Co., Ltd. DODSON, JUSTIN C §102§103§112 Non-Final OA — Pending Nov 09, 2023
18289530 COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE S&E Bio Co., Ltd. LARA, CAROLINE MONSERRAT 1633 §103§112Other Non-Final OA 33d Pending Nov 03, 2023
18288160 SYSTEM FOR SUPERVISION OF THE OPERATION AND MAINTENANCE OF INDUSTRIAL EQUIPMENT Seadvance SIMPSON, DIONE N 3628 §101 Non-Final OA — Pending Oct 24, 2023
18287843 METHOD, SYSTEM AND ELECTRONIC WEARABLE UNIT FOR CONTROLLING ELECTRICAL STIMULATION TO PELVIC REGION OF A SUBJECT Indian Institute Of Science TEHRANI, DANIEL 3792 §102§103 Non-Final OA — Pending Oct 20, 2023
18284252 COLORIMETRIC BIOSENSOR, PREPARATION METHOD THEREOF, AND ANTIBIOTIC SUSCEPTIBILITY TESTING METHOD USING THE SAME Inha University Research And Business Foundation BREEN, KIMBERLY CATHERINE 1657 §103 Final Rejection — Pending Sep 26, 2023
18283424 SPIRULINA-BASED COMPOSITION AND USES THEREOF FOR REINFORCING IMMUNITY Axeen Pharma AFREMOVA, VERA 1653 §102§103§112 Final Rejection — Pending Sep 21, 2023
18277511 KIT FOR TREATING DAMAGED NERVES Reddress Ltd. ALTER MORSCHAUSER, ALYSSA MARGO 3796 DP Final Rejection 203d overdue Pending Aug 16, 2023
18270165 COMPOSITION FOR INHIBITING METASTASIS AND ENHANCING ANTICANCER DRUG SENSITIVITY Korea Advanced Institute Of Science And Technology GROOMS, TIFFANY NICOLE 1637 §103§112 Non-Final OA — Pending Jun 28, 2023
18204867 METHOD OF ASSEMBLING CONDUIT SECTIONS S-P Products, Inc. LEGASPI, EUGENE REY DEVERA 3729 §103§112 Non-Final OA 22d Pending Jun 01, 2023
18198632 CONDUIT COUPLING S-P Products, Inc. BESLER, CHRISTOPHER JAMES 3726 §102§103Other Non-Final OA — Pending May 17, 2023
18035500 METHOD FOR PRODUCING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE S&E Bio Co., Ltd. SPENCE, JENNIFER SUZANNE 1633 §103§112DP Final Rejection — Pending May 04, 2023
18035214 TWO-PHASE CONTROL VALVE FOR ELECTRICAL POWER SYSTEM Raval A.C.S. Ltd. WALKE, AMANDA C 1722 §102 Non-Final OA — Pending May 03, 2023
18140842 METHOD OF ULTRASONICALLY CLEANING A VESSEL Realmthree Ltd. BERGNER, ERIN FLANAGAN 1713 §103 Final Rejection 29d Pending Apr 28, 2023
18295520 CONTACT LENS COMPOSITIONS AND METHODS OF USE THEREOF Ps Therapy, Inc. PALLAY, MICHAEL B 1617 §103 Non-Final OA 87d overdue Pending Apr 04, 2023
18028396 COATING OF MATERIALS WITH BIOSURFACTANT COMPOUNDS Stellenbosch University BREEN, KIMBERLY CATHERINE 1657 §103§112 Non-Final OA — Pending Mar 24, 2023
18027889 NOVEL LACTIC ACID BACTERIA AND USE THEREOF Nvp Healthcare Co., Ltd. DURYEE, ALEXANDER MARSH 1657 §103 Non-Final OA 11d overdue Pending Mar 22, 2023
18026566 SURFACE-COATING FLUID COMPOSITION FOR ABSORBING AND DIFFUSING VOLATILE COMPOUNDS Ceva Sante Animale BROOKS, KREGG T 1764 §103 Final Rejection 11d overdue Pending Mar 15, 2023
18022026 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS Københavns Universitet CRUM, MARY ABOU NADER 1657 §101§102§112 Non-Final OA — Pending Feb 17, 2023
18077894 METHOD OF PREDICTING THERAPEUTIC RESPONSE AND PROGNOSIS OF METASTATIC BREAST CANCER TO CHEMOTHERAPEUTIC AGENTS, AND TREATING METASTATIC BREAST CANCER Samsung Electronics CREWS, JARET JAMES 1691 §112 Non-Final OA — Pending Dec 08, 2022
17963270 MIXTURE OF PYRETHROIDS AND MILBEMYCINS AND USES THEREOF Valent Biosciences LLC VIGIL, TORIANA NICHOLE 1612 §103 Non-Final OA 17d overdue Pending Oct 11, 2022
17906722 GPC3 CAR- T CELLS SECRETING IL-18 AND METHODS OF MAKING AND USING THE SAME Eutilex Co., Ltd. BRETZ, COREY LANE 1635 §103§112DP Non-Final OA — Pending Sep 19, 2022
17901137 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID FOR THINNING OF FRUITS Valent Biosciences LLC ROBINSON, KEITH O NEAL 1661 §103 Non-Final OA — Pending Sep 01, 2022
17907905 POWER BATTERY COVER AND POWER BATTERY Shenzhen Kedali Industry Co., Ltd. EGGERDING, ALIX ECHELMEYER 1729 §103 Non-Final OA 78d Pending Aug 29, 2022
17793324 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION Ceva Santé Animale KASSA, TIGABU 1619 §103 Non-Final OA 59d overdue Pending Jul 15, 2022
17790385 METHOD FOR OBTAINING A MAMMALIAN CELL LINE THAT EXPRESSES A RECOMBINANT EQUINE CHORIONIC GONADOTROPIN (RECG), THE RECOMBINANT CELL LINES PRODUCING RECG, LARGE-SCALE RECG PRODUCTION METHOD, RECG, FORMULATIONS CONTAINING RECG, NUCLEIC ACIDS ENCODING FOR RECG AND USES Natalia Ceaglio HAMMELL, NEIL P 1681 §112 Final Rejection — Pending Jun 30, 2022
17699405 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF Eye Therapies, LLC HAGHIGHATIAN, MINA 1616 §103 Final Rejection 267d overdue Pending Mar 21, 2022
17257206 METHOD FOR PREDICTING RESPONSE TO ANTICANCER IMMUNOTHERAPY USING DNA METHYLATION ABERRATION Pentamedix Co., Ltd. SALMON, KATHERINE D 1682 §101§103§112 Final Rejection — Pending Mar 07, 2022
17637001 Pumping System Smith & Loveless Inc. DAVIS, JASON GREGORY 3745 §103§112 Final Rejection — Pending Feb 21, 2022
17621959 METHOD FOR CARING FOR THE SKIN OR COAT OF ANIMALS Ceva Santé Animale S.A. WESTERBERG, NISSA M 1618 §103DP Final Rejection — Pending Dec 22, 2021
17620425 A METHOD FOR DETECTING AN ANALYTE Psyros Diagnostics Limited DUNN, MCKENZIE A 1678 §103DP Non-Final OA 26d Pending Dec 17, 2021
17604360 CYBB LENTIVIRAL VECTOR, LENTIVIRAL VECTOR-TRANSDUCED STEM CELL, AND PREPARATION METHOD AND APPLICATION THEREOF BEIJING MEIKANG GENO-IMMUNE BIOTECHNOLOGY CO., LTD. JOHNSON, ALLISON MARIE 1638 §103 Final Rejection — Pending Oct 15, 2021
17458101 DEVICE FOR THE TREATMENT OF MALARIA Carmenza Spadafora MUTCHLER, CHRISTOPHER JOHN 3796 §102§103 Non-Final OA — Pending Aug 26, 2021
17405773 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF Eye Therapies, LLC HAGHIGHATIAN, MINA 1616 §103 Final Rejection 267d overdue Pending Aug 18, 2021
17389556 ANTI-VIRAL COMPOSITIONS AND METHODS OF USE THEREOF Eye Therapies LLC MERCIER, MELISSA S 1615 §103§112 Non-Final OA 56d Pending Jul 30, 2021
17137985 BACILLUS AMYLOLIQUEFACIENS AND NEONICOTINOIDS MIXTURES AND METHODS OF USE THEREOF Valent U.S.A. LLC PIPIC, ALMA 1617 §103 Final Rejection 89d overdue Pending Dec 30, 2020
16933527 Equation Learning Neural Networks in Degrading Channels for Neural Machine Maintenance and Applications Thereof Nanoscope Technologies, LLC VASSELL, MEREDITH ABBOTT 1687 §101§112 Final Rejection — Pending Jul 20, 2020
16852870 MIXTURES OF SABADILLA ALKALOIDS AND PYRETHROIDS AND USES THEREOF Mclaughlin Gormley King Company HAGOPIAN, CASEY SHEA 1617 — Final Rejection 70d Pending Apr 20, 2020

Managing Wood, Phillips, Katz, Clark & Mortimer's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month